Related references
Note: Only part of the references are listed.Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms
Coen D. A. Stehouwer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study
Gillian L. Booth et al.
LANCET (2006)
Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes
AP Boright et al.
DIABETES (2005)
Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin:: randomised, double blind, placebo controlled trial (the DIABHYCAR study)
M Marre et al.
BRITISH MEDICAL JOURNAL (2004)
Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients
S Hadjadj et al.
DIABETIC MEDICINE (2003)
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
W Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data
N Chaturvedi
ANNALS OF INTERNAL MEDICINE (2001)
The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and Ramipril (DIABHYCAR) study:: Design, organization, and patient recruitment
M Lièvre et al.
CONTROLLED CLINICAL TRIALS (2000)
Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories - The Hoorn study
F de Vegt et al.
DIABETES CARE (2000)
Share Paper
